Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

Open in Screener

INSP

Inspire Medical Systems Inc

Sep 20 • 03:18PM ET

212.92

Dollar change +0.82
Percentage change 0.39	%

Healthcare • Medical Devices • USA • NYSE

Chart Stock Detail • Compare Perf. • Short Interest • Financials • Options • Save to Portfolio • Create Alert

Held by: VTI VB VXF VBK IHI IWP SCHA IWF IWR SCHM

Index	-	P/E	1171.82	EPS (ttm)	0.18	Insider Own	1.96%	Shs Outstand	29.56M	Perf Week	4.38%
Market Cap	6.35B	Forward P/E	152.71	EPS next Y	1.39	Insider Trans	-13.00%	Shs Float	29.24M	Perf Month	13.66%
Income	6.01M	PEG	-	EPS next Q	0.07	Inst Own	106.13%	Short Float	4.45%	Perf Quarter	31.06%
Sales	705.71M	P/S	9.00	EPS this Y	203.56%	Inst Trans	2.59%	Short Ratio	2.01	Perf Half Y	9.06%
Book/sh	21.41	P/B	9.95	EPS next Y	86.98%	ROA	0.89%	Short Interest	1.30M	Perf Year	6.56%
Cash/sh	14.74	P/C	14.44	EPS next 5Y	-	ROE	1.03%	52W Range	123.00 - 257.40	Perf YTD	4.66%
Dividend Est.	-	P/FCF	-	EPS past 5Y	13.57%	ROI	0.91%	52W High	-17.28%	Beta	1.34
Dividend TTM	-	Quick Ratio	8.35	Sales past 5Y	66.60%	Gross Margin	84.83%	52W Low	73.11%	ATR (14)	8.89
Dividend Ex-Date	-	Current Ratio	9.25	EPS Y/Y TTM	114.08%	Oper. Margin	-2.03%	RSI (14)	68.21	Volatility	4.31% 4.07%
Employees	1011	Debt/Eq	0.04	Sales Y/Y TTM	34.14%	Profit Margin	0.85%	Recom	1.75	Target Price	226.38
Option/Short	Yes / Yes	LT Debt/Eq	0.04	EPS Q/Q	178.75%	Payout	-	Rel Volume	1.07	Prev Close	212.10
Sales Surprise	3.60%	EPS Surprise	328.90%	Sales Q/Q	29.65%	Earnings	Aug 06 AMC	Avg Volume	646.26K	Price	212.92
SMA20	7.99%	SMA50	22.29%	SMA200	15.14%	Trades		Volume	620,200	Change	0.39%

Date	Action	Analyst	Rating Change	Price Target Change
May-08-24	Downgrade	BofA Securities	Buy → Neutral	$265 → $225
Apr-19-24	Initiated	RBC Capital Mkts	Outperform	$285
Mar-19-24	Initiated	Morgan Stanley	Overweight	$250
Feb-06-24	Resumed	KeyBanc Capital Markets	Overweight	$278
Jan-19-24	Initiated	Jefferies	Buy	$245
Jan-02-24	Downgrade	Stifel	Buy → Hold	$210
Dec-13-23	Downgrade	Wells Fargo	Overweight → Equal Weight	$245 → $187
Jul-19-23	Initiated	Robert W. Baird	Outperform	$371
Apr-14-23	Initiated	Mizuho	Buy	$300
Mar-29-23	Initiated	UBS	Buy	$300
Dec-13-22	Upgrade	Goldman	Neutral → Buy	$245 → $308
Dec-13-22	Initiated	KeyBanc Capital Markets	Overweight	$287
Apr-13-22	Initiated	Truist	Buy	$315
Apr-06-22	Initiated	Wolfe Research	Peer Perform	$270
Mar-02-22	Resumed	BofA Securities	Buy	$270
Jan-04-21	Downgrade	BofA Securities	Buy → Neutral
Dec-15-20	Downgrade	Goldman	Buy → Neutral	$162 → $209
Nov-03-20	Upgrade	Oppenheimer	Underperform → Perform
Nov-03-20	Upgrade	BofA Securities	Neutral → Buy	$125 → $155
Sep-22-20	Initiated	JP Morgan	Overweight	$148

Show Previous Ratings

Sep-18-24 09:50AM	Here's Why Inspire Medical Systems (INSP) is a Strong Momentum Stock (Zacks)
Sep-06-24 06:43PM	Palantir Technologies, Dell Technologies, and Erie Indemnity Set to Join S&P 500; Others to Join S&P MidCap 400 and S&P SmallCap 600 (PR Newswire) +7.44%
Sep-02-24 09:50AM	Why Inspire Medical Systems (INSP) is a Top Momentum Stock for the Long-Term (Zacks)
Aug-23-24 07:35AM	Should You Establish a Position in Inspire Medical Systems (INSP)? (Insider Monkey)
Aug-21-24 04:02PM	Inspire Medical Systems, Inc. to Present at Upcoming Investor Conferences (GlobeNewswire)
12:20PM	Loading…
Aug-09-24 12:20PM	Why Inspire (INSP) Might be Well Poised for a Surge (Zacks)
Aug-07-24 10:48AM	Inspire Medical (INSP) Q2 Earnings Beat, Gross Margin Rises (Zacks) +28.14%
Aug-06-24 06:30PM	Compared to Estimates, Inspire (INSP) Q2 Earnings: A Look at Key Metrics (Zacks)
05:35PM	Inspire Medical Systems (INSP) Tops Q2 Earnings Estimates (Zacks)
04:02PM	Inspire Medical Systems, Inc. Board Authorizes Share Repurchase Program (GlobeNewswire)
04:02PM	Inspire Medical Systems, Inc. Announces Second Quarter 2024 Financial Results and Updates 2024 Outlook (GlobeNewswire)
Aug-05-24 10:10AM	Inspire Medical (INSP) Gets FDA Nod for Inspire V System (Zacks)
09:16AM	Wall Street's Insights Into Key Metrics Ahead of Inspire (INSP) Q2 Earnings (Zacks)
Aug-02-24 08:00AM	Inspire Medical Systems, Inc. Announces FDA Approval of the Inspire V System (GlobeNewswire)
Jul-29-24 10:59AM	Sleep Apnea Device Marker Inspire's Stock Rises on Improved Outlook (Investopedia) +6.22%
09:21AM	Loading…
09:21AM	Should You Consider Adding Inspire Medical Systems (INSP) Now to Your Portfolio? (Insider Monkey)
06:45AM	Inspire Medical Systems, Inc. Announces Preliminary Results for Second Quarter of 2024 and Updates 2024 Revenue Outlook (GlobeNewswire)
Jul-23-24 08:00AM	Inspire Medical Systems, Inc. Announces Countrywide Reimbursement in France (GlobeNewswire)
Jul-22-24 11:35AM	Inspire Medical's (INSP) Inspire Therapy Gets CE Mark Approval (Zacks)
08:39AM	Is This The Right Entry Point To Add Inspire Medical Systems (INSP)? (Insider Monkey)
08:00AM	Inspire Medical Systems, Inc. Announces the Appointment of Melissa J. Mann as Chief People Officer (GlobeNewswire)
04:52AM	Inspire Medical secures CE Mark of MRI compatibility for Inspire IV device (Medical Device Network)
Jul-19-24 08:00AM	Inspire Medical Systems, Inc. Announces CE Mark Certification under the European Union's Medical Device Regulation for Inspire Therapy (GlobeNewswire)
08:00AM	Inspire Medical Systems, Inc. Announces CE Mark Certification of Full-Body MRI Compatibility under the European Union's Medical Device Regulation (GlobeNewswire)
Jul-13-24 08:36AM	Inspire Medical (INSP) Gave Back its Gains in Q2 (Insider Monkey)
Jul-10-24 11:08AM	Inspire Medical (INSP) Dips on FDA Recall of IPG Model 3028 (Zacks)
Jul-09-24 03:17PM	FDA Labels Inspire Medical's Sleep Apnea Nerve Stimulator Recall As Most Serious (Benzinga)
Jul-02-24 08:00AM	Inspire Medical Systems, Inc. to Report Second Quarter 2024 Financial Results on August 6, 2024 (GlobeNewswire)
Jun-25-24 08:30AM	Does Inspire Medical Systems (INSP) Hava Ample Growth Opportunity, Considering Low Market Share? (Insider Monkey)
Jun-24-24 04:10PM	Eli Lilly's Weight-Loss Drug Takes Down ResMed, Inspire Medical Again (Investor's Business Daily) -16.72%
02:01PM	Loading…
02:01PM	How Lilly is joining Novo in the crusade to circumvent Medicare's block on weight loss drugs (Yahoo Finance)
10:08AM	Stocks to Watch Monday: Target, Meta, Coinbase, Nvidia, Apple (The Wall Street Journal)
Jun-06-24 11:31AM	Why Is Inspire (INSP) Down 7.3% Since Last Earnings Report? (Zacks)
Jun-04-24 08:00AM	Inspire Medical Systems, Inc. to Present at the Truist Securities Medtech Conference (GlobeNewswire)
May-28-24 06:00AM	7 Undervalued Stocks That Could Triple Your Money by 2026 (InvestorPlace)
May-23-24 08:00AM	Inspire Medical Systems, Inc. to Present at the Jefferies Global Healthcare Conference (GlobeNewswire)
May-21-24 12:40PM	Three Reasons to Retain Inspire Medical (INSP) Stock for Now (Zacks)
May-09-24 09:35AM	Inspire (INSP) Loses -31.98% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner (Zacks) +6.71%
May-08-24 01:49PM	Inspire Medical Systems, Inc. (NYSE:INSP) Q1 2024 Earnings Call Transcript (Insider Monkey) -33.47%
11:33AM	Inspire Medical (INSP) Q1 Earnings Beat, Gross Margin Up (Zacks)
10:16AM	Q1 2024 Inspire Medical Systems Inc Earnings Call (Thomson Reuters StreetEvents)
09:30AM	Inspire (INSP) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates (Zacks)
07:31AM	Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday (InvestorPlace)
May-07-24 08:59PM	INSP Stock Earnings: Inspire Medical Systems Beats EPS, Beats Revenue for Q1 2024 (InvestorPlace)
05:46PM	Inspire Medical Systems Inc (INSP) Surpasses Revenue Estimates and Narrows Quarterly Loss (GuruFocus.com)
05:10PM	Inspire Medical Systems (INSP) Reports Q1 Loss, Tops Revenue Estimates (Zacks)
04:02PM	Inspire Medical Systems, Inc. Announces First Quarter 2024 Financial Results and Updates 2024 Outlook (GlobeNewswire)
May-03-24 09:15AM	Gear Up for Inspire (INSP) Q1 Earnings: Wall Street Estimates for Key Metrics (Zacks)
Apr-30-24 06:15PM	Inspire Medical Systems (INSP) Stock Moves -0.8%: What You Should Know (Zacks)
03:39PM	Inspire Medical Systems Stock Sees IBD RS Rating Rise To 78 (Investor's Business Daily)
08:00AM	Inspire Medical Systems, Inc. to Present at the BofA Securities 2024 Health Care Conference (GlobeNewswire)
Apr-26-24 09:14AM	Notice to Long-Term Shareholders of Inspire Medical Systems, Inc. (INSP): Grabar Law Office Is Investigating Claims on Your Behalf (Newsfile)
Apr-18-24 12:17PM	Why You Should Add Inspire Medical (INSP) to Your Portfolio (Zacks)
02:14AM	Inspire (INSP) Surges 9.9%: Is This an Indication of Further Gains? (Zacks)
Apr-17-24 08:38AM	Eli Lilly Stock Gains After Study Shows Weight-Loss Drug Helps With Sleep Apnea (The Wall Street Journal) +9.87%
Apr-08-24 05:17AM	Notice to Long-Term Shareholders of Inspire Medical Systems, Inc. (INSP): Grabar Law Office Is Investigating Claims on Your Behalf (Newsfile)
Apr-02-24 08:00AM	Inspire Medical Systems, Inc. to Report First Quarter 2024 Financial Results on May 7, 2024 (GlobeNewswire)
Mar-27-24 07:00PM	Director Jerry Griffin Sells Shares of Inspire Medical Systems Inc (INSP) (GuruFocus.com)
Mar-21-24 02:31AM	Director Jerry Griffin Sells Shares of Inspire Medical Systems Inc (INSP) (GuruFocus.com)
Mar-18-24 12:01PM	Here's Why You Should Retain Inspire Medical (INSP) Stock Now (Zacks)
Mar-14-24 01:49AM	Director Jerry Griffin Sells Shares of Inspire Medical Systems Inc (INSP) (GuruFocus.com)
Mar-05-24 08:00AM	Inspire Medical Systems, Inc. to Present at the KeyBanc Life Sciences & MedTech Investor Forum (GlobeNewswire)
Feb-13-24 09:02AM	Fundamentals Appear Positive: KeyBanc Suggests 2 MedTech Stocks With up to ~40% Upside (TipRanks)
05:45AM	Investors in Inspire Medical Systems, Inc. Should Contact Levi & Korsinsky Before February 20, 2024 to Discuss Your Rights - INSP (PR Newswire)
Feb-07-24 11:33AM	Q4 2023 Inspire Medical Systems Inc Earnings Call (Thomson Reuters StreetEvents) -10.55%
11:15AM	Inspire Medical Systems, Inc. (NYSE:INSP) Q4 2023 Earnings Call Transcript (Insider Monkey)
10:02AM	Inspire Medical (INSP) Q4 Earnings Top Estimates, Gross Margin Up (Zacks)
Feb-06-24 06:30PM	Compared to Estimates, Inspire (INSP) Q4 Earnings: A Look at Key Metrics (Zacks)
05:35PM	Inspire Medical Systems (INSP) Surpasses Q4 Earnings and Revenue Estimates (Zacks)
04:35PM	Inspire Medical Systems Inc Reports Robust Q4 and Full Year 2023 Results (GuruFocus.com)
04:02PM	Inspire Medical Systems, Inc. Announces Fourth Quarter and Full Year 2023 Financial Results and Reaffirms 2024 Outlook (GlobeNewswire)
Feb-05-24 08:00AM	Inspire Medical Systems, Inc. Announces Chair Marilyn Carlson Nelson to Retire and Timothy P. Herbert named Chair and Chief Executive Officer (GlobeNewswire)
Feb-04-24 06:56AM	Five Upcoming Class Actions for Investors to Know About (TipRanks)
Feb-01-24 06:55AM	Inspire Medical Systems (INSP) Experienced Volatility in 2023 (Insider Monkey)
Jan-30-24 10:00AM	Inspire Medical Systems (INSP) Expected to Beat Earnings Estimates: Should You Buy? (Zacks)
Jan-26-24 08:00AM	Inspire Medical Systems, Inc. Announces Jerry C. Griffin, M.D. to Retire from its Board after Sixteen Years of Service (GlobeNewswire)
Jan-24-24 10:15AM	INSPIRE MEDICAL SHAREHOLDER NOTICE: Faruqi & Faruqi Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $100,000 In Inspire Medical To Contact Him Directly To Discuss Their Options (GlobeNewswire)
Jan-19-24 01:12AM	Here's Why Inspire Medical Systems (INSP) Underperformed the Broader Market (Insider Monkey)
Jan-10-24 10:45AM	INSPIRE MEDICAL SHAREHOLDER NOTICE: Faruqi & Faruqi Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $100,000 In Inspire Medical To Contact Him Directly To Discuss Their Options (GlobeNewswire)
Jan-09-24 10:39AM	Inspire Medical (INSP) Reports Solid Preliminary Q4 Revenues (Zacks)
08:00AM	Inspire Medical Systems, Inc. to Report Fourth Quarter and Fiscal 2023 Financial Results on February 6, 2024 (GlobeNewswire)
Jan-08-24 08:00AM	Inspire Medical Systems, Inc. Announces Preliminary Results for the Fourth Quarter and Full Year 2023 and Provides Initial 2024 Guidance (GlobeNewswire) +9.15%
Jan-05-24 01:07PM	Inspire Medical Systems, Inc. Investors With Large Losses Should Contact Robbins LLP for Information About Their Rights and Remedies Against INSP (Business Wire)
Dec-29-23 09:00AM	3 Reasons to Hold Inspire Medical (INSP) Stock in Your Portfolio (Zacks)
Dec-28-23 08:00AM	Inspire Medical Systems, Inc. Announces Appointment of Seasoned Medical Device Executive Myriam J. Curet, M.D. to its Board of Directors (GlobeNewswire)
Dec-27-23 06:26PM	15 Best Fast Growth Stocks to Buy Now (Insider Monkey)
05:05AM	Inspire Medical Systems (INSP) Fell on Concerns about Weight Loss Drug (Insider Monkey)
Dec-21-23 10:30PM	Inspire Medical Systems (INSP) Fell on Growing Use of Weight Loss Drug (Insider Monkey) +5.67%
Dec-18-23 08:00AM	Inspire Medical Systems, Inc. to Present at the 42nd Annual J.P. Morgan Healthcare Conference (GlobeNewswire)
Dec-07-23 11:30AM	Inspire (INSP) Up 16.8% Since Last Earnings Report: Can It Continue? (Zacks) +6.04%
06:08AM	Should You Sell Inspire Medical Systems (INSP)? (Insider Monkey)
Nov-30-23 11:20AM	3 Reasons to Retain Inspire Medical (INSP) Stock for Now (Zacks)
Nov-14-23 03:58PM	FMR LLC Bolsters Portfolio with Inspire Medical Systems Inc Acquisition (GuruFocus.com) +6.25%
08:00AM	Inspire Medical Systems, Inc. to Present at the Piper Sandler 35th Annual Healthcare Conference (GlobeNewswire)
Nov-11-23 01:34PM	Inspire Medical Systems (INSP) Fell on Fears Relating to Increasing Adoption of Weight Loss Drugs (Insider Monkey)
Nov-09-23 12:41PM	Inspire Medical (INSP) Q3 Earnings Top Estimates, Revenues Lag (Zacks)
Nov-08-23 05:52PM	Inspire Medical Systems, Inc. (NYSE:INSP) Q3 2023 Earnings Call Transcript (Insider Monkey) -19.66%
07:30AM	LifeLens Technologies Expands Executive Leadership Team and Board of Directors (GlobeNewswire)
Nov-07-23 04:03PM	Inspire Medical Systems, Inc. Announces Third Quarter 2023 Financial Results and Updates 2023 Outlook (GlobeNewswire)
Nov-01-23 08:00AM	Inspire Medical Systems, Inc. to Present at the Stifel 2023 Healthcare Conference (GlobeNewswire) +6.23%

Inspire Medical Systems, Inc. engages in the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea. It offers inspire therapy, which consists of a remote control and implantable components that includes pressure sensing lead, a neurostimulator, and a stimulation lead. The company was founded by Timothy P. Herbert in November 2007 and is headquartered in Golden Valley, MN.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Ebeling Philip	Officer	Sep 11 '24	Proposed Sale	247.28	5,453	1,348,445		Sep 11 06:01 PM
McCormick Shawn	Director	Sep 09 '24	Sale	220.00	800	176,000	23,140	Sep 11 05:02 PM
Rondoni John	Chief Technology Officer	Sep 09 '24	Sale	215.00	31	6,665	11,348	Sep 11 05:01 PM
SHAWN T MCCORMICK	Director	Sep 09 '24	Proposed Sale	220.00	800	176,000		Sep 09 04:09 PM
JOHN RONDONI	Officer	Sep 09 '24	Proposed Sale	215.00	31	6,665		Sep 09 04:08 PM
Rondoni John	Chief Technology Officer	Aug 22 '24	Option Exercise	71.00	5,000	355,000	16,379	Aug 23 04:09 PM
Rondoni John	Chief Technology Officer	Aug 22 '24	Sale	189.83	5,000	949,143	11,379	Aug 23 04:09 PM
JOHN RONDONI	Officer	Aug 22 '24	Proposed Sale	189.82	5,000	949,100		Aug 22 04:22 PM
Ban Randy	Chief Commercial Officer	Aug 15 '24	Option Exercise	42.15	16,139	680,259	19,195	Aug 19 08:14 PM
Ban Randy	Chief Commercial Officer	Aug 16 '24	Option Exercise	42.15	4,861	204,891	7,917	Aug 19 08:14 PM
Ban Randy	Chief Commercial Officer	Aug 15 '24	Sale	193.10	16,139	3,116,397	3,056	Aug 19 08:14 PM
Ban Randy	Chief Commercial Officer	Aug 16 '24	Sale	188.55	4,861	916,549	3,056	Aug 19 08:14 PM
RANDALL A BAN	Officer	Aug 16 '24	Proposed Sale	188.55	4,861	916,560		Aug 16 04:34 PM
Ebeling Philip	Officer	Aug 15 '24	Proposed Sale	194.84	43,901	8,553,615		Aug 15 05:36 PM
McCormick Shawn	Director	Aug 14 '24	Option Exercise	0.94	8,537	8,025	23,940	Aug 15 04:19 PM
RANDALL A BAN	Officer	Aug 15 '24	Proposed Sale	193.10	16,139	3,116,380		Aug 15 04:13 PM
Ebeling Philip	Officer	Aug 14 '24	Proposed Sale	190.03	4,596	873,393		Aug 14 04:50 PM
Griffin Jerry C	Director	Jul 26 '24	Proposed Sale	126.53	5,952	753,086		Jul 26 05:02 PM
McCormick Shawn	Director	May 10 '24	Option Exercise	0.94	2,500	2,350	15,403	May 13 04:30 PM
NELSON MARILYN C	Director	Apr 29 '24	Option Exercise	240.68	1,175	282,799	35,620	May 01 04:01 PM
Buchholz Richard	Chief Financial Officer	Apr 17 '24	Sale	230.03	15,000	3,450,450	28,271	Apr 18 04:44 PM
Herbert Timothy P.	CEO and President	Apr 01 '24	Sale	205.09	40,000	8,203,581	63,658	Apr 03 07:44 PM
Griffin Jerry C	Director	Apr 01 '24	Option Exercise	16.00	296	4,736	10,932	Apr 03 04:55 PM
Griffin Jerry C	Director	Apr 01 '24	Sale	213.99	32	6,848	10,900	Apr 03 04:55 PM
NELSON MARILYN C	Director	Apr 01 '24	Option Exercise	16.00	3,273	52,368	34,338	Apr 02 08:29 PM
NELSON MARILYN C	Director	Mar 27 '24	Option Exercise	90.85	3,243	294,633	31,065	Mar 29 04:49 PM
Griffin Jerry C	Director	Mar 25 '24	Option Exercise	16.00	1,000	16,000	11,190	Mar 27 04:01 PM
Griffin Jerry C	Director	Mar 25 '24	Sale	197.81	554	109,587	10,636	Mar 27 04:01 PM
Rondoni John	Chief Technology Officer	Mar 22 '24	Sale	194.40	4,387	852,849	11,270	Mar 26 08:23 PM
Griffin Jerry C	Director	Mar 18 '24	Option Exercise	16.00	1,000	16,000	10,744	Mar 20 05:51 PM
Griffin Jerry C	Director	Mar 18 '24	Sale	193.53	554	107,216	10,190	Mar 20 05:51 PM
Griffin Jerry C	Director	Mar 11 '24	Option Exercise	16.00	1,000	16,000	10,298	Mar 13 09:21 PM
Griffin Jerry C	Director	Mar 11 '24	Sale	198.05	554	109,720	9,744	Mar 13 09:21 PM
Griffin Jerry C	Director	Mar 01 '24	Option Exercise	16.00	1,000	16,000	9,852	Mar 05 05:08 PM
Griffin Jerry C	Director	Mar 01 '24	Sale	179.44	554	99,410	8,298	Mar 05 05:08 PM
NELSON MARILYN C	Director	Mar 01 '24	Option Exercise	0.94	2,555	2,402	27,822	Mar 05 05:06 PM
Rondoni John	Chief Technology Officer	Feb 29 '24	Sale	179.25	8,605	1,542,441	15,657	Mar 04 06:21 PM
Ban Randy	Chief Commercial Officer	Feb 27 '24	Option Exercise	42.15	3,060	128,979	6,089	Feb 27 08:39 PM
Ban Randy	Chief Commercial Officer	Feb 23 '24	Option Exercise	4.11	12,230	50,234	15,259	Feb 27 08:39 PM
Ban Randy	Chief Commercial Officer	Feb 23 '24	Sale	185.37	12,230	2,267,075	3,029	Feb 27 08:39 PM
Ban Randy	Chief Commercial Officer	Feb 27 '24	Sale	182.01	3,060	556,951	3,029	Feb 27 08:39 PM
Rondoni John	Chief Technology Officer	Feb 15 '24	Option Exercise	2.07	8,000	16,560	24,262	Feb 16 04:05 PM
NELSON MARILYN C	Director	Feb 09 '24	Option Exercise	0.94	4,000	3,760	25,267	Feb 13 04:01 PM
Jandrich Steven	VP, Human Resources	Jan 30 '24	Option Exercise	0.94	16,225	15,252	23,096	Jan 31 08:40 PM
Sparks Charisse Y	Chief Medical Officer	Oct 12 '23	Buy	153.50	100	15,350	998	Jan 24 04:32 PM
NELSON MARILYN C	Director	Oct 17 '23	Option Exercise	0.94	2,000	1,880	21,100	Oct 17 07:52 PM
Herbert Timothy P.	CEO and President	Oct 12 '23	Option Exercise	5.43	208,036	1,128,811	203,691	Oct 16 07:53 PM
NELSON MARILYN C	Director	Sep 21 '23	Option Exercise	0.94	2,000	1,880	18,959	Sep 25 06:30 PM

Open in Screener

NVRO

Nevro Corp

Sep 20 • 03:18PM ET

5.76

Dollar change -0.09
Percentage change -1.61	%

Healthcare • Medical Devices • USA • NYSE

Chart Stock Detail • Compare Perf. • Short Interest • Financials • Options • Save to Portfolio • Create Alert

Held by: VTI IWM VXF IWN IHI XHE SCHA VTWO VHT IWC

Index	RUT	P/E	-	EPS (ttm)	-2.12	Insider Own	5.66%	Shs Outstand	36.36M	Perf Week	-0.59%
Market Cap	214.58M	Forward P/E	-	EPS next Y	-2.63	Insider Trans	0.00%	Shs Float	35.17M	Perf Month	5.42%
Income	-77.44M	PEG	-	EPS next Q	-0.82	Inst Own	100.16%	Short Float	8.48%	Perf Quarter	-34.82%
Sales	426.10M	P/S	0.50	EPS this Y	-8.15%	Inst Trans	-1.51%	Short Ratio	4.34	Perf Half Y	-58.44%
Book/sh	7.37	P/B	0.78	EPS next Y	5.14%	ROA	-13.21%	Short Interest	2.98M	Perf Year	-71.25%
Cash/sh	7.34	P/C	0.78	EPS next 5Y	-	ROE	-27.22%	52W Range	4.38 - 22.64	Perf YTD	-73.25%
Dividend Est.	-	P/FCF	-	EPS past 5Y	-9.37%	ROI	-16.18%	52W High	-74.58%	Beta	0.94
Dividend TTM	-	Quick Ratio	3.53	Sales past 5Y	2.01%	Gross Margin	64.91%	52W Low	31.35%	ATR (14)	0.46
Dividend Ex-Date	-	Current Ratio	4.77	EPS Y/Y TTM	-2494.48%	Oper. Margin	-22.03%	RSI (14)	47.78	Volatility	7.57% 7.20%
Employees	1215	Debt/Eq	0.88	Sales Y/Y TTM	1.59%	Profit Margin	-18.18%	Recom	3.53	Target Price	7.32
Option/Short	Yes / Yes	LT Debt/Eq	0.75	EPS Q/Q	23.00%	Payout	-	Rel Volume	0.62	Prev Close	5.85
Sales Surprise	-2.76%	EPS Surprise	23.99%	Sales Q/Q	-4.27%	Earnings	Aug 06 AMC	Avg Volume	686.67K	Price	5.76
SMA20	3.64%	SMA50	-18.01%	SMA200	-53.68%	Trades		Volume	382,446	Change	-1.61%

Date	Action	Analyst	Rating Change	Price Target Change
Aug-09-24	Upgrade	Citigroup	Sell → Neutral
Aug-08-24	Upgrade	Wolfe Research	Underperform → Peer Perform
Aug-07-24	Downgrade	Wells Fargo	Equal Weight → Underweight	$13 → $5.50
Aug-07-24	Downgrade	JP Morgan	Neutral → Underweight
Aug-07-24	Downgrade	JMP Securities	Mkt Outperform → Mkt Perform
May-22-24	Downgrade	Citigroup	Neutral → Sell	$13.50 → $9
Feb-22-24	Downgrade	Oppenheimer	Outperform → Perform
Jan-12-24	Downgrade	RBC Capital Mkts	Outperform → Sector Perform	$23 → $20
Dec-21-23	Downgrade	Canaccord Genuity	Buy → Hold	$23
Jul-19-23	Initiated	Robert W. Baird	Neutral	$26
May-31-23	Initiated	RBC Capital Mkts	Outperform	$40
May-15-23	Upgrade	Oppenheimer	Perform → Outperform	$40
Apr-14-23	Initiated	Mizuho	Neutral	$40
Jan-17-23	Downgrade	Citigroup	Buy → Neutral	$40
Jan-06-23	Downgrade	Piper Sandler	Neutral → Underweight	$42 → $38
Dec-20-22	Upgrade	Canaccord Genuity	Hold → Buy	$41 → $67
Dec-12-22	Downgrade	Wells Fargo	Overweight → Equal Weight	$66 → $43
Oct-12-22	Initiated	Jefferies	Underperform	$31
May-05-22	Upgrade	Citigroup	Neutral → Buy	$78
Apr-13-22	Resumed	Truist	Hold	$72 → $80

Show Previous Ratings

Sep-19-24 04:30PM	Nevro Announces New Employee Inducement Grants Under NYSE Rule 303A.08 (PR Newswire)
Sep-12-24 01:20AM	Vanguard Group Inc's Strategic Reduction in Nevro Corp Holdings (GuruFocus.com) +8.28%
Aug-28-24 04:15PM	Nevro to Present at Wells Fargo 2024 Healthcare Conference (PR Newswire) +10.07%
Aug-20-24 01:04PM	Here's Why You Should Retain Nevro (NVRO) Stock for Now (Zacks) -6.47%
Aug-14-24 04:30PM	Nevro Announces New Employee Inducement Grants Under NYSE Rule 303A.08 (PR Newswire) -6.18% +12.21%
05:13PM	Loading…
Aug-13-24 05:13PM	Engaged Capital Calls Nevro Corp. (NVRO) to Focus on Improving Profitability and Stop Pursuing Acquisitions (Insider Monkey)
Aug-09-24 08:22AM	Why Is Nevro Corp. (NVRO) a Good Buy According to Engaged Capital? (Insider Monkey) +6.00%
Aug-08-24 01:38AM	Nevro considers sale as competition for pain market ramps up (MedTech Dive) +17.39%
Aug-07-24 01:01PM	Nevro's (NVRO) Q2 Earnings Beat Estimates, Revenues Down Y/Y (Zacks) -44.42%
Aug-06-24 05:55PM	Nevro (NVRO) Reports Q2 Loss, Misses Revenue Estimates (Zacks)
04:52PM	Nevro: Q2 Earnings Snapshot (Associated Press Finance)
04:05PM	Nevro Reports Second-Quarter 2024 Financial Results (PR Newswire)
Jul-11-24 04:15PM	Nevro Announces New Employee Inducement Grants Under NYSE Rule 303A.08 (PR Newswire) +9.99%
01:58PM	Here's Why You Should Retain Nevro (NVRO) Stock for Now (Zacks)
Jul-09-24 04:15PM	Nevro to Report Second-Quarter 2024 Financial Results and Host Earnings Conference Call on August 6, 2024 (PR Newswire) -9.08% +5.26%
08:30AM	Loading…
Jun-28-24 08:30AM	Nevro Announces New Employee Inducement Grants Under NYSE Rule 303A.08 (PR Newswire)
Jun-11-24 04:15PM	Nevro to Present at Truist Securities MedTech Conference (PR Newswire)
Jun-06-24 11:31AM	Why Is Nevro (NVRO) Down 8.8% Since Last Earnings Report? (Zacks)
Jun-04-24 12:37PM	Here's Why You Should Retain Nevro (NVRO) Stock for Now (Zacks)
Jun-03-24 04:13AM	Here's Why Nevro Corp. (NVRO) Shares Detracted from Performance (Insider Monkey)
May-24-24 04:15PM	Nevro Announces New Employee Inducement Grants Under NYSE Rule 303A.08 (PR Newswire)
May-09-24 04:05PM	Nevro to Present at BofA Securities 2024 Healthcare Conference (PR Newswire) -6.85%
May-08-24 02:57PM	Truist Securities Lowers Nevro's Price Target to $11 From $14, Hold Rating Maintained (MT Newswires) -11.88%
02:07PM	Nevro Corp. (NYSE:NVRO) Q1 2024 Earnings Call Transcript (Insider Monkey)
12:14PM	Nevro's (NVRO) Q1 Earnings and Sales Beat Estimates, Margins Up (Zacks)
12:12PM	Piper Sandler Adjusts Nevro's Price Target to $12 From $15, Maintains Underweight Rating (MT Newswires)
11:03AM	Wells Fargo Trims Nevro Price Target to $13 From $14, Maintains Equal Weight Rating (MT Newswires)
06:56AM	Q1 2024 Nevro Corp Earnings Call (Thomson Reuters StreetEvents)
03:50AM	Nevro Corp (NVRO) Q1 2024 Earnings Call Transcript Highlights: A Detailed Review of Financial ... (GuruFocus.com)
May-07-24 09:56PM	NVRO Stock Earnings: Nevro Beats EPS, Beats Revenue for Q1 2024 (InvestorPlace)
05:30PM	Loading…
05:30PM	Nevro (NVRO) Reports Q1 Loss, Tops Revenue Estimates (Zacks)
04:27PM	Nevro: Q1 Earnings Snapshot (Associated Press Finance)
04:05PM	Nevro Reports First-Quarter 2024 Financial Results (PR Newswire)
Apr-17-24 08:30AM	Nevro to Report First-Quarter 2024 Financial Results and Host Earnings Conference Call on May 7, 2024 (PR Newswire)
Mar-21-24 12:35PM	Here's Why You Should Retain Nevro (NVRO) Stock for Now (Zacks)
Feb-29-24 07:29AM	Nevro (NVRO) Gets FDA Nod for SI Fixation Without Lateral Screw (Zacks)
Feb-28-24 04:10PM	Nevro Receives FDA 510(k) Clearance to Use SI Fixation System Without Need to Include Lateral Screw (PR Newswire)
Feb-22-24 06:21PM	Why Nevro Stock Lagged the Market on Thursday (Motley Fool) -7.33%
11:20AM	Nevro Corp. (NYSE:NVRO) Q4 2023 Earnings Call Transcript (Insider Monkey)
10:50AM	Nevro's (NVRO) Q4 Earnings and Sales Top Estimates, Margins Up (Zacks)
06:40AM	Q4 2023 Nevro Corp Earnings Call (Thomson Reuters StreetEvents)
Feb-21-24 05:20PM	Nevro (NVRO) Reports Q4 Loss, Tops Revenue Estimates (Zacks)
04:43PM	Nevro Corp (NVRO) Reports Modest Revenue Growth Amidst Strategic Shifts (GuruFocus.com)
04:21PM	Nevro: Q4 Earnings Snapshot (Associated Press Finance)
04:06PM	Nevro Enters Into Cooperation Agreement With Engaged Capital (PR Newswire)
04:05PM	Nevro Reports Fourth-Quarter and Full-Year 2023 Financial Results (PR Newswire)
Feb-14-24 10:00AM	Will Nevro (NVRO) Report Negative Earnings Next Week? What You Should Know (Zacks)
Feb-01-24 04:30PM	Nevro Announces Consensus Statement Supporting High-Frequency (10 kHz) Spinal Cord Stimulation Therapy for Refractory Painful Diabetic Neuropathy (PR Newswire) -5.57%
Jan-29-24 04:30PM	Nevro to Report Fourth-Quarter and Full-Year 2023 Financial Results and Host Conference Call on February 21, 2024 (PR Newswire) -5.56%
Jan-22-24 05:00AM	Top 4 Spinal Injury Stocks for 2024 (NRX.V, NVRO, SYK, BSX) (News Direct)
Jan-19-24 10:48AM	Nevro's (NVRO) SCS Therapy Gets Positive Coverage Update (Zacks)
Jan-18-24 04:15PM	Nevro Announces Positive Coverage Update from Carelon Healthcare for the Treatment of Painful Diabetic Neuropathy (PR Newswire)
Jan-17-24 04:15PM	Nevro to Highlight 25 Scientific Abstracts at 2024 North American Neuromodulation Society (NANS) Annual Meeting (PR Newswire)
Jan-14-24 05:28PM	Billionaire Steve Cohen Aggressively Bought These 12 Stocks Recently (Insider Monkey)
Jan-10-24 09:41AM	Nevro's (NVRO) Preliminary Q4 Revenues Boosted by PDN Sales (Zacks)
12:43AM	Nevro laying off 63 people to strengthen financial position (MedTech Dive)
Jan-09-24 08:30AM	Nevro Announces Preliminary Fourth-Quarter and Full-Year 2023 Revenue Results (PR Newswire)
Jan-04-24 04:15PM	Nevro to Present at 42nd Annual J.P. Morgan Healthcare Conference (PR Newswire)
Dec-26-23 11:45AM	3 Reasons to Retain Nevro (NVRO) in Your Portfolio for Now (Zacks)
Dec-12-23 06:56AM	Activist investor takes stake in Nevro amid struggles to grow neuromodulation sales (MedTech Dive)
Dec-04-23 06:07AM	Nevro buys low back pain company Vyrsa for $40M (MedTech Dive)
Dec-01-23 11:31AM	Nevro (NVRO) Up 15.7% Since Last Earnings Report: Can It Continue? (Zacks) +8.66%
11:16AM	Nevro's (NVRO) Latest Buyout to Boost SI Joint Pain Treatment (Zacks)
Nov-30-23 05:19PM	Nevro Announces Acquisition of Vyrsa Technologies (PR Newswire)
Nov-23-23 09:55AM	Wall Street Analysts Predict a 36.66% Upside in Nevro (NVRO): Here's What You Should Know (Zacks)
Nov-21-23 09:14AM	Nevro's (NVRO) New Data Supports SCS Therapy for NSRBP Treatment (Zacks)
Nov-20-23 07:00AM	Nevro Delivers Long-Term Relief with High-Frequency Spinal Cord Stimulation: 24-Month Data Demonstrates Profound Improvements for Non-Surgical Refractory Back Pain (PR Newswire)
Nov-02-23 06:33PM	Nevro Corp. (NYSE:NVRO) Q3 2023 Earnings Call Transcript (Insider Monkey) +7.35%
12:16PM	Nevro (NVRO) Q3 Earnings Top Estimates, FY23 Revenue View Up (Zacks)
08:33AM	Q3 2023 Nevro Corp Earnings Call (Thomson Reuters StreetEvents)
Nov-01-23 07:29PM	Nevro Corp (NVRO) Q3 2023 Earnings: 3% Revenue Growth and $25.6M Net Loss from Operations (GuruFocus.com)
04:26PM	Nevro: Q3 Earnings Snapshot (Associated Press Finance)
04:01PM	Nevro Reports Third Quarter 2023 Financial Results, Provides Fourth Quarter Guidance and Updates Full-Year 2023 Guidance (PR Newswire)
Oct-25-23 10:02AM	Nevro (NVRO) Expected to Beat Earnings Estimates: What to Know Ahead of Q3 Release (Zacks)
Oct-04-23 07:00AM	Nevro to Report Third Quarter 2023 Financial Results (PR Newswire)
Sep-18-23 07:00AM	New Data Demonstrate the Health Economic Benefits of Nevro's High-Frequency Spinal Cord Stimulation Therapy (PR Newswire)
02:23AM	Heres Why Nevro Corp. (NVRO) Declined in Q2 (Insider Monkey)
Aug-23-23 07:00AM	Nevro Announces Participation in Upcoming Investor Conferences (PR Newswire)
Aug-18-23 01:01PM	Nevro's (NVRO) New Data Supports SCS Therapy for PDN Treatment (Zacks)
Aug-16-23 07:00AM	New 24-Month Data Shows Nevro's SCS Therapy Provides Highly Effective, Long-Term Relief from Painful Diabetic Neuropathy (PR Newswire)
Aug-15-23 10:32AM	Nevro's (NVRO) Latest Launch to Customize Chronic Pain Treatment (Zacks)
Aug-10-23 04:52AM	Nevro announces launch of HFX Connect in Europe and CE marking of expanded labelling for the HFX SCS system. (PR Newswire)
Aug-02-23 03:40PM	Why Shares of Nevro Are Down Wednesday (Motley Fool) -18.69%
11:28AM	Nevro (NVRO) Q2 Earnings Lag Estimates, FY23 View Cut (Zacks)
Aug-01-23 05:45PM	Nevro (NVRO) Reports Q2 Loss, Misses Revenue Estimates (Zacks)
04:40PM	Nevro: Q2 Earnings Snapshot (AP Finance)
04:03PM	Nevro Reports Second Quarter 2023 Financial Results, Provides Third Quarter Guidance and Updates Full-Year 2023 Guidance (PR Newswire)
Jul-31-23 09:43AM	MedTech Stocks to Watch for Earnings on Aug 1: ECL, NVRO, INSP (Zacks)
Jul-27-23 09:15AM	Integer (ITGR) Tops Q2 Earnings and Revenue Estimates (Zacks)
Jul-13-23 07:00AM	Nevro Announces Presentations at American Society of Pain & Neuroscience Fifth Annual Conference (PR Newswire)
Jul-12-23 07:00AM	Nevro to Present at the Canaccord Genuity 43rd Annual Growth Conference (PR Newswire)
Jun-27-23 07:00AM	Nevro to Report Second Quarter 2023 Financial Results (PR Newswire)
Jun-23-23 07:00AM	Nevro Announces Painful Diabetic Neuropathy Clinical Data Presentations at the American Diabetes Association 83rd Scientific Sessions (PR Newswire)
Jun-19-23 10:27AM	3 Reasons to Retain Nevro (NVRO) Stock in Your Portfolio (Zacks)
Jun-07-23 08:04AM	10 Little-Known Stocks Billionaires Are Loading Up On (Insider Monkey)
Jun-05-23 04:05PM	Nevro Names New Chief Commercial Officer (PR Newswire) -14.68%
Jun-02-23 11:31AM	Why Is OPKO Health (OPK) Down 17.2% Since Last Earnings Report? (Zacks)
May-22-23 07:00AM	Nevro to Present at Jefferies Healthcare Conference (PR Newswire)
May-18-23 06:52AM	Nevro Corp.'s (NYSE:NVRO) 26% Dip Still Leaving Some Shareholders Feeling Restless Over Its P/ERatio (Simply Wall St.)
Apr-27-23 04:05PM	Nevro Corp. Announces New Employment Inducement Grant under Section 303A.08 of the NYSE Listed Company Manual (PR Newswire) -12.34%

Nevro Corp. engages in the development of medical devices. The firm focuses on providing products that improve the quality of life of patients suffering from debilitating chronic pain. It develops and commercializes the senza spinal cord stimulation system, an evidence-based neuromodulation platform for the treatment of chronic pain. The company was founded by Konstantinos Alataris in March 2006 and is headquartered in Redwood City, CA.

INSP

Inspire Medical Systems Inc

NVRO

Nevro Corp

Upgrade your FINVIZ experience